Orrstown Financial Services Inc. decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 4,423 shares of the healthcare conglomerate’s stock after selling 160 shares during the period. UnitedHealth Group makes up 2.3% of Orrstown Financial Services Inc.’s investment portfolio, making the stock its 5th largest holding. Orrstown Financial Services Inc.’s holdings in UnitedHealth Group were worth $1,551,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in UNH. Two Sigma Advisers LP boosted its stake in shares of UnitedHealth Group by 195.8% during the 2nd quarter. Two Sigma Advisers LP now owns 760,600 shares of the healthcare conglomerate’s stock valued at $224,339,000 after purchasing an additional 503,500 shares in the last quarter. Findlay Park Partners LLP boosted its stake in shares of UnitedHealth Group by 69.0% during the 3rd quarter. Findlay Park Partners LLP now owns 1,225,000 shares of the healthcare conglomerate’s stock valued at $381,918,000 after purchasing an additional 500,000 shares in the last quarter. Morgan Stanley boosted its stake in UnitedHealth Group by 4.9% during the third quarter. Morgan Stanley now owns 7,003,292 shares of the healthcare conglomerate’s stock worth $2,183,416,000 after acquiring an additional 325,936 shares in the last quarter. CIBC Private Wealth Group LLC boosted its stake in UnitedHealth Group by 25.5% during the third quarter. CIBC Private Wealth Group LLC now owns 1,579,134 shares of the healthcare conglomerate’s stock worth $492,232,000 after acquiring an additional 321,008 shares in the last quarter. Finally, Nuveen Asset Management LLC boosted its stake in UnitedHealth Group by 4.4% during the second quarter. Nuveen Asset Management LLC now owns 7,294,171 shares of the healthcare conglomerate’s stock worth $2,151,416,000 after acquiring an additional 305,797 shares in the last quarter. 86.39% of the stock is currently owned by hedge funds and other institutional investors.

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 98,579 shares of the company’s stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $329.47, for a total transaction of $32,478,823.13. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Richard T. Burke sold 7,000 shares of the company’s stock in a transaction that occurred on Tuesday, December 8th. The shares were sold at an average price of $349.78, for a total transaction of $2,448,460.00. Following the sale, the director now directly owns 159,487 shares of the company’s stock, valued at $55,785,362.86. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 130,253 shares of company stock valued at $43,485,730. 0.80% of the stock is owned by corporate insiders.

Several research firms recently commented on UNH. Oppenheimer boosted their price objective on shares of UnitedHealth Group from $353.00 to $375.00 and gave the stock an “outperform” rating in a research note on Thursday, October 15th. Truist boosted their price objective on shares of UnitedHealth Group from $400.00 to $420.00 in a research note on Tuesday, January 5th. Argus lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, October 19th. UBS Group boosted their price objective on shares of UnitedHealth Group from $319.00 to $330.00 and gave the stock a “neutral” rating in a research note on Friday, October 16th. Finally, Piper Sandler lifted their target price on shares of UnitedHealth Group from $385.00 to $409.00 and gave the stock an “overweight” rating in a report on Wednesday, November 11th. Seven investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the stock. UnitedHealth Group has an average rating of “Buy” and a consensus target price of $383.50.

Shares of UNH traded down $2.33 during mid-day trading on Wednesday, hitting $355.04. 1,972,017 shares of the company traded hands, compared to its average volume of 3,410,015. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.84 and a current ratio of 0.82. The stock has a 50-day moving average price of $344.91 and a two-hundred day moving average price of $322.55. UnitedHealth Group Incorporated has a 1 year low of $187.72 and a 1 year high of $367.95. The stock has a market cap of $336.87 billion, a price-to-earnings ratio of 20.53, a P/E/G ratio of 1.53 and a beta of 0.68.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Monday, October 19th. The healthcare conglomerate reported $3.51 earnings per share for the quarter, beating the consensus estimate of $2.98 by $0.53. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The firm had revenue of $65.12 billion during the quarter, compared to analysts’ expectations of $63.97 billion. During the same period in the previous year, the company earned $3.88 earnings per share. The firm’s quarterly revenue was up 7.9% on a year-over-year basis. On average, analysts forecast that UnitedHealth Group Incorporated will post 16.78 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th were issued a dividend of $1.25 per share. The ex-dividend date was Friday, December 4th. This represents a $5.00 dividend on an annualized basis and a yield of 1.41%. UnitedHealth Group’s dividend payout ratio is currently 33.09%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.

See Also: Technical Analysis of Stocks, How Can It Help

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.